OBS Pakistan Pvt. Ltd.
Anjum F. has over three decades of experience in the pharmaceutical industry, currently serving as Senior Managing Director and Executive Director of Operations & Business Ventures at OBS Pakistan Pvt. Ltd., a leading healthcare group in Pakistan. Anjum has held various leadership roles, including Managing Director and Director of Marketing and Sales at OBS, where a strong focus on partnerships with multinational and reputable national companies has been emphasized. Previous experience includes management consulting at The SEARLE Company Ltd., where responsibilities included advising on operations and representing the company at regulatory and government forums, and a Chief Executive role at Askari Pharmaceuticals, overseeing significant sales and management restructuring. Anjum's early career included notable positions at Eli Lilly & Company, leading marketing initiatives and strategic business planning, as well as a Product Manager role at Pfizer Laboratories. Anjum holds an MBA in Marketing from the Institute of Business Administration.
This person is not in any teams
This person is not in any offices
OBS Pakistan Pvt. Ltd.
1 followers
The OBS Group is one of Pakistan’s leading corporations in the healthcare segment with presence in Pakistan and Sri Lanka. OBS commenced operations in 1963 and became a name associated with quality medicine throughout Pakistan in 2006 after entering into a strategic alliance with Organon (part of Akzo Nobel). Since then, OBS has fostered strategic alliances with many reputable international firms including Organon, Merck & Co Inc, USA, Schering Plough, AstraZeneca, Mylan USA, Vifor Switzerland and Santen Pharma Japan. At present, OBS ranks as the 8th largest pharmaceutical player in Pakistan amongst 704 companies with a group turnover in excess of PKR 9,300 million and profits of over PKR 2,000 mn. We a have a strong presence all over Pakistan with over 300 professionally trained sales representatives covering more than 25,000 healthcare professionals across the country. Our key focus areas include Anti-Infective, Cardiology, CNS, Diabetes & Metabolic Disorders, Gastroenterology, Ophthalmology, Respiratory, Women’s Health (Infertility, HRT & Contraception) and Vaccines. We have 106 pharmaceutical brands and 7 consumer brands in Pakistan and 12 pharmaceutical brands in Sri Lanka along with a strong presence in Afghanistan. The OBS Group is now looking to tap markets in Vietnam and Uzbekistan with various products which are under registration. We continuously invest on upgrading our information systems which enable us to scientifically grow our business and help the management to have effective controls and further improve efficiency of the organization. In addition to the systems we also strongly believe that people are the most important asset for our organization. We believe in equal employment opportunity and harnessing diversity in our group companies. We regularly invest in the training and development of our human resource through both internal and external training and development programs.